Cargando…
Clinical development of gene- and cell-based therapies: overview of the European landscape
In the last decade, many clinical trials with gene- and cell-based therapies were performed and increasing interest in the development was established by (national) authorities, academic developers, and commercial companies. However, until now only eight products have received marketing authorizatio...
Autores principales: | de Wilde, Sofieke, Guchelaar, Henk-Jan, Zandvliet, Maarten Laurens, Meij, Pauline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130079/ https://www.ncbi.nlm.nih.gov/pubmed/27990447 http://dx.doi.org/10.1038/mtm.2016.73 |
Ejemplares similares
-
An overview of Personalized Medicine landscape and policies in the European Union
por: Beccia, F, et al.
Publicado: (2022) -
The pharmacogenomic landscape of an Indigenous Australian population
por: Samarasinghe, Sumudu Rangika, et al.
Publicado: (2023) -
Protection of haematopoietic progenitor cell donors: an updated overview of the European landscape
por: Sánchez Ibáñez, Jacinto, et al.
Publicado: (2023) -
Physical Examination of Potential Deceased Organ and Tissue Donors: An Overview of the European Landscape
por: Chandrasekar, Akila, et al.
Publicado: (2023) -
Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes
por: Sand, Laurens G. L., et al.
Publicado: (2015)